Myopia Control Efficacy of Spectacle Lenses With Aspherical Lenslets: Results of a 3-Year Follow-Up Study

屈光度 医学 眼科 奇观 随机对照试验 外科 视力 市场经济 经济
作者
Xue Li,Yingying Huang,Ziang Yin,Chenyao Liu,Siqi Zhang,Adeline Yang,Björn Drobe,Hao Chen,Jinhua Bao
出处
期刊:American Journal of Ophthalmology [Elsevier]
卷期号:253: 160-168 被引量:55
标识
DOI:10.1016/j.ajo.2023.03.030
摘要

To investigate myopia control efficacy in children who continued wearing spectacle lenses with highly aspherical lenslets (HAL) or switched from spectacle lenses with slightly aspherical lenslets (SAL) and single-vision spectacle lenses (SVL) to HAL for 1 year after a 2-year myopia control trial.This was a 1-year extension of a randomized clinical trial.Of 54 children who had worn HAL for 2 years, 52 continued wearing HAL (HAL1 group), and of the 53 and 51 children who had originally worn SAL or SVL, 51 and 48 switched to wearing HAL (HAL2 and HAL3 groups) in year 3, respectively. A new SVL (nSVL) group of 56 children was recruited, matched for age, sex, cycloplegic spherical equivalent refraction (SER), and axial length (AL) of the HAL3 group at extension baseline, and used for a comparison of third-year changes. SER and AL were measured every 6 months in year 3.During year 3, the mean (SE) myopia progression in the nSVL group was -0.56 (0.05) diopters (D). Compared with nSVL, the changes in SER were less in HAL1 (-0.38 [0.05] D, P = .02), HAL2 (-0.36 [0.06] D, P = .01), and HAL3 (-0.33 [0.06] D, P = .005). The mean (SE) AL elongation in the nSVL group was 0.28 (0.02) mm. Compared with nSVL, the elongation in AL was less in the HAL1 (0.17 [0.02] mm, P < .001), HAL2 (0.18 [0.02] mm, P < .001), and HAL3 (0.14 [0.02] mm, P < .001) groups. Myopia progression and axial elongation were comparable in all 3 HAL groups (all P > .05) in year 3.Myopia control efficacy has remained in children who wore HAL in the previous 2 years. Children who switched from SAL or SVL to HAL in year 3 had slower myopia progression and axial elongation than that in the control group.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
烟花应助感冒灵采纳,获得30
刚刚
666发布了新的文献求助10
刚刚
M跃发布了新的文献求助10
1秒前
1秒前
赘婿应助Evander采纳,获得10
1秒前
1秒前
JamesPei应助图图采纳,获得10
2秒前
打打应助干净的尔柳采纳,获得10
2秒前
单薄的英姑完成签到,获得积分10
2秒前
张子怡发布了新的文献求助10
2秒前
李健的小迷弟应助孙颖采纳,获得10
2秒前
稀里哗啦完成签到,获得积分10
3秒前
xiao发布了新的文献求助10
3秒前
善学以致用应助leemonster采纳,获得10
3秒前
可靠笑容发布了新的文献求助10
4秒前
5秒前
阿奶完成签到,获得积分10
6秒前
科研一路绿灯完成签到,获得积分10
6秒前
小猪完成签到,获得积分10
6秒前
6秒前
量子星尘发布了新的文献求助10
8秒前
思源应助ff采纳,获得10
8秒前
9秒前
苗条的向雪完成签到 ,获得积分10
10秒前
SciGPT应助M跃采纳,获得10
11秒前
勤奋太君发布了新的文献求助20
12秒前
昏睡的保温杯完成签到,获得积分10
12秒前
JamesPei应助典雅的纸飞机采纳,获得10
12秒前
Evander发布了新的文献求助10
12秒前
凡千灵溪完成签到 ,获得积分10
12秒前
ding应助小高爱学习采纳,获得10
13秒前
孤独凝芙完成签到,获得积分20
13秒前
aldehyde应助xiao采纳,获得10
14秒前
MYunn完成签到,获得积分10
16秒前
17秒前
17秒前
小药丸完成签到 ,获得积分10
17秒前
难过白易完成签到,获得积分10
17秒前
科研通AI2S应助虎虎采纳,获得10
19秒前
zzsl发布了新的文献求助10
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
The Social Work Ethics Casebook: Cases and Commentary (revised 2nd ed.).. Frederic G. Reamer 1070
Introduction to Early Childhood Education 1000
2025-2031年中国兽用抗生素行业发展深度调研与未来趋势报告 1000
List of 1,091 Public Pension Profiles by Region 871
Alloy Phase Diagrams 500
A Guide to Genetic Counseling, 3rd Edition 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 遗传学 催化作用 冶金 量子力学 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 5420180
求助须知:如何正确求助?哪些是违规求助? 4535297
关于积分的说明 14149461
捐赠科研通 4452280
什么是DOI,文献DOI怎么找? 2442103
邀请新用户注册赠送积分活动 1433615
关于科研通互助平台的介绍 1410869